Two quotes, one 22% "savings," and a question that ruined my morning
In March 2024 I had two face moisturizer quotes open in the same spreadsheet. Vendor A came in at $2.40 per unit. Vendor B came in at $1.87. Same core formula on paper — glycerin, squalane, panthenol, a couple of humectants. I highlighted the $1.87 cell and typed "22% savings" in the notes column.
Then our ops lead leaned over and asked one question: "Is that 30 ml or 50 ml?"
Vendor B's quote was for a 30 ml jar. Vendor A's was for 50 ml. Normalized, B was about 30% more expensive, not 22% cheaper. I'd spent the better part of a week on a comparison that compared nothing.
For context: I'm the procurement manager at a 40-person skincare brand. I've managed our contract manufacturing budget — roughly $620,000 a year — for six years, negotiated with more than 20 vendors, and logged every order in our cost tracking system. And I still almost walked straight into that one.
If you're sourcing face moisturizers for the first time, or the fifth, the number on the quote sheet is the smallest part of what you'll actually pay. Here's where the rest of it hides.
Why "price per unit" is close to meaningless on its own
Fill weight is the first distortion, and it's the most common one. A 30 ml jar and a 50 ml jar are not the same product at different prices — they're different amounts of the same claim. Until you convert both to cost per milliliter (or per gram, for anything with a dense oil phase), you're comparing two different things and calling it a discount.
MOQ is the second. A quote at $1.10 per unit on a 25,000-unit minimum isn't cheaper than $1.60 at 3,000 units if your realistic quarterly sell-through is 4,000 units. You're not buying a price at that point. You're buying inventory, warehouse space, and a write-off you'll deal with in eight months.
And the third distortion is the one that took me years to see clearly: the quote sheet prices a formula. Almost nothing else in a face moisturizer program lives in the formula.
I want to say it was my fourth year before I started building quotes as total-cost-of-ownership models instead of price comparisons. It might have been my fifth. Either way, too long.
You're not sourcing a moisturizer. You're sourcing a line.
When we planned our last range, the product brief had five positions: a face moisturizer for dry skin, a face moisturizer for men, a face moisturizer with SPF, a face moisturizer for sensitive skin, and a natural face moisturizer. Five bullet points in a strategy deck. In procurement terms, that's five SKUs — five MOQs, five sets of stability data, five label revisions, five inventory risks, five chances to guess wrong about demand.
Here's the part that genuinely surprised me. Chemically, three of those five were nearly the same emulsion. Same oil phase. Same emulsifier system. Same base. What actually differed was fragrance load, the preservative package, the pump, and the words printed on the front of the tube.
Base emulsions are cheap. Differentiation is where the money goes.
SPF is a regulatory cliff, not an ingredient
In the US, a product carrying an SPF claim on the label is regulated as an over-the-counter drug rather than a cosmetic (FDA's OTC sunscreen monograph, 21 CFR Part 352). That single sentence reshapes the entire sourcing conversation. Drug manufacturing carries different facility expectations, different recordkeeping, and testing that is tied to the formula and the process that produced it.
The expensive part isn't the UV filters. It's that changing the fragrance, swapping an emulsifier, or moving from a jar to an airless pump can force you to re-establish the SPF value you already paid to establish once. On our first SPF line, testing and re-testing was the largest single line item in the project — more than the packaging, more than the fill.
If you're a smaller brand, my honest recommendation is to run face moisturizer with SPF as its own project with its own budget and its own timeline. Treating it as a variant of an existing cream is how a $9,000 line item quietly becomes a $30,000 one.
Natural and sensitive-skin sit at the expensive end of the shelf
This is counterintuitive enough that I'll say it plainly: a natural face moisturizer is usually the most expensive SKU in the range, not the cheapest.
Water-based emulsions need preservation. A short, "clean" preservative list often means a narrower antimicrobial margin, which means more challenge testing, tighter control over water activity, and packaging that keeps fingers out of the jar. Airless pumps and tubes cost more than jars. Shelf-life verification takes longer. There's an entire invisible budget line here, and it never appears on a quote sheet.
Same logic applies to a face moisturizer for sensitive skin. Fragrance-free is one decision. Proving the claim is another. "Dermatologist-tested" is not a phrase you can simply print because it reads well.
The claim on the front of the tube is a cost center
Per FTC guidance, advertising claims have to be truthful, not misleading, and substantiated with evidence — before you run them, not after someone asks. That applies to "natural" and "gentle" every bit as much as it applies to a discount claim.
FTC advertising guidelines require that claims be truthful and not misleading, substantiated with evidence, and clear about endorsements and testimonials. — FTC, Business Guidance on Advertising and Marketing
I've watched a brand spend four months building a launch around one claim, then discover the substantiation testing was never in the budget. The formula was fine. The claim was the problem. And claims aren't retrofittable — you either have the data or you rewrite the packaging, which means new artwork, new labels, new everything.
What this actually cost us
Over our 2023 fiscal year we ran four face moisturizer SKUs across two contract manufacturers. When I audited total spend instead of unit prices — a habit I should have built two years earlier — about $18,400 sat in categories no quote sheet had ever mentioned:
- Re-testing after a packaging change (jar to airless pump on the sensitive skill SKU): $9,200
- Excess inventory on the men's SKU after over-ordering to hit an MOQ: roughly $6,100, combining write-off and discounting — though I might be misremembering the exact split
- Label and artwork reprints after two claim revisions: about $3,100
Call it 3% of our annual contract manufacturing budget, spent on things we could have planned for in advance.
When I finally put Q1 and Q3 side by side — same manufacturer, same base formula, different packaging format — the whole thing clicked. Identical formula. 41% higher cost. Every dollar of the difference was packaging and re-validation. I had spent two years negotiating ingredient pricing that was never the problem.
There was also a decision I'd rather not relive. In Q2 2024 we needed a reorder before a container cutoff and had about two hours to confirm a spec change. Normally I'd get a written testing quote first. There was no time. I approved it on a phone call. In hindsight I should have pushed back on the cutoff and taken the extra day — the "no cost" spec change triggered a re-test we hadn't budgeted, and that one was on me.
On the other side of the ledger: we nearly launched all five SKUs at once. We launched three. The two we held back would have added roughly $11,000 in testing and tooling before we had a single sell-through data point. We dodged that one mostly by accident, which is not a strategy I'd recommend.
And I still kick myself for not getting our fill weight tolerance in writing early. I had a verbal "we'll hold ±2%" from an account manager. When a batch arrived light, there was nothing to point at. Maybe $1,400 in real dollars. It changed how I run every sourcing relationship since.
What I do now instead
None of this is exotic. It's normalization and written specs, and it took me longer to build the habit than I'd like to admit.
- Normalize before comparing. Per-ml cost, fill weight, MOQ, lead time, and packaging format all in the same row before anyone discusses price.
- Ask for the testing matrix in the RFP, not after. Which tests, on which formula version, triggered by which changes, and who pays.
- Cap the SKU count in phase one. Launch the two positions with the clearest demand; hold the rest as roadmap.
- Quote SPF separately. Separate budget, separate timeline, separate expectations.
- Put the load-bearing promises in writing — fill weight tolerance, change-order costs, re-test responsibility.
I'd rather spend twenty minutes walking a new supplier through this than spend three months discovering it in a re-test invoice. An informed buyer asks better questions and gets to a signed spec faster. Nobody's doing anyone a favor there — it's just a less expensive way to work.
Bottom line: when you're comparing face moisturizer sourcing quotes, the number that matters isn't the number in the price column. It's everything that number quietly assumes.